Stay updated with breaking news from Nasdaq Ipsc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Century Therapeutics, Inc. (NASDAQ:IPSC – Get Free Report) has been given a consensus rating of “Moderate Buy” by the six brokerages that are covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12-month price objective among […]
Century Therapeutics (NASDAQ:IPSC – Get Free Report) and Athira Pharma (NASDAQ:ATHA – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, dividends, earnings, analyst recommendations, profitability and risk. Valuation and Earnings This table compares Century […]
Century Therapeutics, Inc. (NASDAQ:IPSC – Get Free Report) has received an average recommendation of “Moderate Buy” from the six brokerages that are currently covering the company, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1 year price target among […]
- Accomplished leader with over 20 years of broad-ranging experience across the healthcare industry - Brent Pfeiffenberger, Pharm.D., MBA ...
Shares of Century Therapeutics, Inc. (NASDAQ:IPSC – Get Free Report) have received a consensus rating of “Moderate Buy” from the seven ratings firms that are covering the company, Marketbeat reports. One investment analyst has rated the stock with a hold rating and six have issued a buy rating on the company. The average 12-month price […]